UPDATED March 29, 2013, with comment from Covidien.
Ethicon
Ethicon lands FDA nod for cordless Enseal G2 tissue sealer
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon won 510(k) clearance from the FDA for its next-generation Enseal tissue sealing device with a self-contained power source.
J&J loses jury trial in vaginal mesh lawsuit amid federal probe
A jury this week sided with a plaintiff in a bellwether product liability lawsuit against Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon’s transvaginal mesh implants.
FDA green-lights Ethicon’s surgical assist device
The FDA gave the green light to Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon’s Enseal G2 surgical sealer.
Ethicon touts the device, the Enseal G2 Articulating, as a "first-of-its-kind articulating advanced energy device." It’s the 2nd in the Enseal product line, improving on the 1st iteration with the ability to bend around structures in the body.
Patient takes the stand in Johnson & Johnson mesh lawsuit | MassDevice.com On Call
MASSDEVICE ON CALL —Plaintiff Linda Gross took the stand this week in a bellwether trial against Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon’s transvaginal mesh implants.
Juror selection begins for Johnson & Johnson transvaginal mesh lawsuits | MassDevice.com On Call
MASSDEVICE ON CALL — A bellwether trial against Johnson & Johnson (NYSE:JNJ) began this month with lawyers beginning to select jurors to hear a lawsuit accusing the healthcare giant of liability patient injuries allegedly caused by the company’s transvaginal mesh implants.
Recalls: Haemonetics warns on potential leaks
FDA OKs Ethicon Biosurgery’s Evarrest surgical patch
The FDA cleared Ethicon Biosurgery’s Evarrest fibrin sealant patch for use during surgery to help stop problematic bleeding, which can raise a patient’s mortality rate to 20% in some cases, the company said.
The Evarrest features a coating of biologics, which can initiate a fibrin clot and help form a flexible patch that adheres to a wound, according to the press release.
J&J surgical stapler recall gets Class I status from the FDA | MassDevice.com On Call
MASSDEVICE ON CALL — Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery’s global surgical stapler recall got Class I status from the FDA over concerns that issues with the devices’ firing mechanisms may injure patients.
Recall: Ethicon Endo-Surgery pulls surgical staplers over performance issues
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon Endo-Surgery pulled more than 500 lots of its Proximate surgical staplers over performance issues that may cause the devices to misfire.
MassDevice.com +3 | The top 3 med-tech stories for July 11, 2012
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.